FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Gu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Gu, J.
(The FASEB Journal. 2005;19:1978-1985.)
© 2005 FASEB

Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics

Zonghai Li*,{ddagger}, Ruijiao Zhao*, Xianghua Wu*,{ddagger}, Ye Sun{dagger}, Ming Yao*, Jinjun Li*, Yuhong Xu*,{dagger},1 and Jianren Gu*,{ddagger},1

* National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Medical College of and
{dagger} School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China; and
{ddagger} Medical college of Fudan University, Shanghai, China

1Correspondence: National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, No.25/2200, Xietu Road, Shanghai 200032, China. E-mail: yhxu@sjtu.edu.cn or nlorg{at}sh163.net

Epidermal growth factor receptor (ErbB1, EGFR) is overexpressed in a variety of human cancer cells. It has been considered as a rational target for drug delivery. To identify novel ligands with specific binding capabilities to EGFR, we screened a phage display peptide library and found an enriched phage clone encoding the amino acid sequence YHWYGYTPQNVI (designated as GE11). Competitive binding assay and Scatchard analysis revealed that GE11 peptide bound specifically and efficiently to EGFR with a dissociation constant of ~22 nM, but with much lower mitogenic activity than with EGF. We showed that the peptides were internalized preferentially into EGFR highly expressing cells, and they accumulated in EGFR overexpressing tumor xenografts after i.v. delivery in vivo. In gene delivery studies, GE11-conjugated polyethylenimine (PEI) vectors were less mitogenic, but still quite efficient at transfecting genes into EGFR highly expressing cells and tumor xenografts. Taken together, GE11 is a potentially safe and efficient targeting moiety for selective drug delivery systems mediated through EGFR.—Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., Gu, J. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.


Key Words: EGFR • peptide synthesis • peptide ligand




This article has been cited by other articles:


Home page
JNMHome page
J. R. Newton, Y. Miao, S. L. Deutscher, and T. P. Quinn
Melanoma Imaging with Pretargeted Bivalent Bacteriophage
J. Nucl. Med., March 1, 2007; 48(3): 429 - 436.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Federation of American Societies for Experimental Biology.